[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 8, 1965

Restriction of Non-Prescription Drugs

Author Affiliations

Assistant Professor of Pharmacy and Pharmaceutical Chemistry San Francisco

JAMA. 1965;191(6):505. doi:10.1001/jama.1965.03080060079036

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—  In your commentary on analgesic abuse and the kidney (JAMA190:238 [Oct 19] 1964) you point to the incomplete and misleading nature of the warning now required by Food and Drug Administration regulation to appear on all packages of phenacetin-containing drugs for over-the-counter use. You also indicate the dangers of aspirin abuse and our lack of knowledge about acetaminophen hazard. You question the wisdom of any label warning directed against abuse, with special reference to ineffectiveness for people whose psychological makeup leads them to excesses. I agree with you that it is not possible by label warning alone to protect the public against hazards of self-medication with these or many other drugs. Unfortunately, such drugs are widely available. Recently the American Pharmaceutical Association has asked for establishment of a federal classification of non-prescription drugs which can be obtained only from pharmacists. Phenacetin-containing drugs would undoubtedly be

First Page Preview View Large
First page PDF preview
First page PDF preview
×